Corporate venture funds in healthcare have a persistent blind spot: they measure success mainly by financial returns. According to a recent analysis, this narrow focus causes them to overlook the strategic value that portfolio companies could bring to the parent organization. The result is a missed opportunity to build durable competitive advantage.
The article argues that when funds chase short-term gains, they fail to align investments with the company's broader goals. That misalignment can lead to deals that look good on paper but do little to strengthen the core business. Over time, the gap between investment activity and strategic impact widens.
The piece calls for a different approach—one that treats strategic value as a primary objective, not an afterthought. By rethinking how healthcare corporate venture funds evaluate and manage their portfolios, companies can turn investments into lasting business impact rather than isolated financial wins.